BBCA PHARMA, a subsidiary of BBCA Group, is the first
pharmaceutical listed company in Anhui province (It was listed in
Shenzhen Stock Exchange in 2000 and the Stock Code is 000153).
Established for almost 60 years, BBCA PHARMA has successively earned a reputation of China’s Top 100
Pharmaceutical Industries for several years since 2006.
Integrating R&D, manufacturing with sales, BBCA
PHARMA has developed into a national high and new tech enterprise,
leading with large-volume transfusion (the annual amount is over
500 million bottles/bags) and assisting by analgesic-antipyretic,
cardiovascular, antibiotic products, etc. 53 international
production lines certified by GMP, its products include more than
ten kinds of dosage forms and 300 varieties of drugs, involving
fields of bio-pharmaceutical, chemical pharmaceutical, Chinese
Herbal Medicine and APIs.
Employing more than 5,000 staff, the sales income of
BBCA PHARMA has been over 3 billion. BBCA PHARMA owns seven
pharmaceutical factories, one National Pharmaceutical R&D
Center, six pharmaceutical marketing companies and one pharmacy
chain with more than 600 pharmacies. In which, the international
business company mainly engage in exporting business of APIs and
preparations, importing raw materials, equipment procurement and
registration of drugs. Varieties of preparations have been
registered and marketed in Myanmar, Vietnam, the Philippines,
Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other
The APIs and preparations of BBCA PHARMA have been
exported not only to developing countries and regions such as Asia,
Africa and Latin America, but also to developed markets such as
Europe, America, Japan and Korea.
BBCA can provide technical services for your enterprise
by utilizing the mature production technologies of various drugs,
and provide the OEM servise as well.
You can contact us in the following ways: